Background: Alzheimer's disease (AD) is the most common form of dementia in the elderly 20 population. Currently, no effective cure is available for AD. According to the amyloid 21 hypothesis, the accumulation and deposition of the amyloid-beta (Aβ) peptides plays a key 22 role in AD pathology. Soluble Aβ (sAβ) oligomers were shown to be synaptotoxic and involved 23 in pathological hypersynchronisation of brain resting-state networks in different transgenic 24 developmental-onset mouse models of amyloidosis. However, the impact of protein 25 overexpression during brain postnatal development may cause additional phenotypes 26 unrelated to AD. To address this concern, we investigated sAβ effects on functional resting-27 state networks in transgenic mature-onset amyloidosis Tet-Off APP (TG) mice.
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(Sigma-Aldricht, Belgium) and specific primers (all from Invitrogen, ThermoFisher Scientific, 152 Belgium) as described previously [32] . The PCR reaction mixture was incubated at 94°C for 3 153 min, then 40 cycles of amplification (94°C, 30 s; 60°C (tTA) or 55°C (APP), 1 min; 72°C, 1 154 min), and finally elongation at 72°C for 4 min.
155
Animal handling. Three groups were subjected to a longitudinal MRI study: a TG group, a 156 tTA group (control for promoter-induced changes) and a wild-type (WT) group (control for DOX-unexpected death (3 TG before week 8, and 1 TG and 1 WT after week 8 post DOX treatment).
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All MRI experiments were performed on spontaneously breathing mice under isoflurane 161 anaesthesia (3% for induction, 2% for animal positioning in the bed and maintenance, Isoflo®, 162 Abbot Laboratories Ltd., Illinois, USA), administered in a gaseous mixture of 33% oxygen (200 163 cc/min) and 66% nitrogen (400 cc/min). To have a reproducible flat-skull position during the 164 MRI experiments, the head of the animals was immobilized in an MRI compatible mouse 165 stereotactic device, including a nose cone in which the anaesthetic gas was delivered, with a 166 tooth bar and blunt earplugs. For the rsfMRI acquisition, a bolus of 0.05 mg/kg with 167 medetomidine (Domitor, Pfizer, Karlsruhe, Germany) was administered subcutaneously (s.c.) 168 and isoflurane was decreased immediately to 1%. Ten minutes after the bolus injection, a 169 continuous infusion of medetomidine (0.1 mg/kg/h) was started and 10 min before the rsfMRI 170 acquisition, isoflurane was decreased and kept to 0.4% to maintain an optimal sedation level 171 for the 10 min acquisition of the rsfMRI data [36, 37] . Afterwards, isoflurane levels were 172 gradually increased to 2% within the 10 next min, according to the respiration of the animals, 
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MRI acquisition. The imaging measurements were performed on a 9.4 T Biospec MRI system 184 (Bruker BioSpin, Germany) with the Paravision 6.0 software (www.bruker.com) using a 185 standard Bruker cross coil set-up with a quadrature volume coil and a 2x2 surface array mouse 186 head receiver coil. Three orthogonal multi-slice Turbo RARE T2-weighted images were 187 acquired to ensure uniform slice positioning (RARE; TR/TE 2500/33 ms; 9 slices of 0.7 mm;
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FOV (20x20) mm 2 ; pixel dimensions (0.078x0.078) mm 2 . A field map was acquired for each 189 animal to assess field homogeneity, followed by local shimming, which corrects for the 190 measured inhomogeneity in an ellipsoid volume of interest (VOI) within the brain. RsfMRI 191 acquisition was performed using a multi-slice T2*-weighted single shot gradient echo (GE) 192 echo planar imaging (EPI) sequence (2D GE-EPI; TR/TE 2000/17 ms; 12 horizontal slices of 193 0.4 mm, slice gap 0.1 mm; 300 repetitions). The field-of-view (FOV) was (20x20) mm 2 and the 194 matrix size (96x64), resulting in voxel dimensions of (0.208x0.313x0.5) mm 3 . The acquisition 195 of the rsfMRI scans started 40 min after the bolus injection and the total scan time was 10 min.
196
Anatomical 3D images were acquired using a 3D RARE sequence (TR/TE 1800/42 ms; RARE 197 factor 16). The reconstructed matrix size was (256x256x128) and FOV (20x20x10) mm 3 , 198 resulting in a voxel resolution of (0.078x0.078x0.078) mm 3 with a total scan duration of 44 min.
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MRI data pre-processing. Pre-processing of the rsfMRI data was performed using SPM12 
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normalization and spatial smoothing, as described previously [29, 37] . Briefly, all rsfMRI 203 images within each session were first realigned to the first image, using a least-squares 204 approach and a 6-parameter rigid body spatial transformation. Then, rsfMRI images were co-205 registered to the subject's 3D RARE scan acquired during the same imaging session using 206 mutual information as the similarity metric. In parallel, an in-house 3D-template, based from 207 3D RARE images of similar mice aged from 3m to 5m old was created with Advanced 208 Normalization Tools (ANTs), using a global 12-parameter affine transformation followed by a 209 nonlinear deformation protocol. This template was used to spatially normalize each 3D RARE 210 scan. Afterwards, all of the transformations (realignment, co-registration and normalisation)
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were applied during the spatial normalization step. Lastly, the rsfMRI data was smoothed in-212 plane, using a Gaussian kernel with full width at half maximum of twice the voxel size (FWHM 213 = 0.416 mm x 0.625 mm). Finally, the rsfMRI data was filtered between 0.01 and 0.1 Hz using 214 the Resting State fMRI Data Analysis toolbox (REST 1.8, http://resting-fmri.sourceforge.net/).
215
MRI data analysis. First, a group Independent Component Analysis (ICA) was performed to 216 determine which brain resting-state networks could be detected, as described previously [29, 217 37]. This analysis was done within the population, including all data sets (3 groups, 4 time 218 points), using the GIFT-toolbox (Group ICA of fMRI toolbox, version 3.0a: 
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Immunohistochemistry. An additional group of mice was used for histology. Brain samples 230 were collected at 8w (N=2/group; actual age: 5m) and 28w post DOX treatment (NWT=1; NTG=1; 231 actual age 10m) as described previously [29] . Briefly, mice were deeply anesthetized following 232 an intraperitoneal injection of 60 mg/ kg/BW pentobarbital (Nembutal; Ceva Sante Animale, 233 Brussels, Belgium), after which a transcardial perfusion first with ice-cold PBS and then with 234 4% paraformaldehyde (Merck Millipore, Merck KGaA, Darmstadt, Germany) was performed.
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Next, brains were surgically removed and post-fixed in 4% paraformaldehyde for 2h. To freeze 236 protect the fixed brains, a sucrose gradient (sucrose, Sigma Aldrich) was applied: 2h at 5%, 237 2h at 10%, and overnight at 20%. Subsequently, brains were snap frozen in liquid nitrogen and 238 stored at −80°C until further processing. Ten-μm sagittal sections were prepared using a 239 cryostat (CryoStar NX70; ThermoScientific). For immunofluorescence analyses, the following primary antibodies were used: chicken anti GFAP (Abcam ab4674) 1:1000, rabbit anti IBA-1 241 (Wako 019-19741) 1:1000, and the following secondary antibodies: donkey anti chicken 242 (Jackson 703-166-155) 1:1000, goat anti rabbit (Jackson 111-096-114) 1:1000. Furthermore,
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TOPRO staining (Life technologies T3605, 1:200) and thioflavin-S staining (Santa Cruz 244 Biotechnology, sc-215969) were performed to, respectively, stain the nuclei and to visualize 245 amyloid plaques. Following staining, sections were mounted using Prolong Gold Antifade 246 (P36930; Invitrogen). All images were acquired using an Olympus BX51 fluorescence 247 microscope equipped with an Olympus DP71 digital camera. Image acquisition was done with 248 CellSens Software (Olympus, Tokyo, Japan, http://www.olympus-global.com). To localize the 249 regions of interest, the mouse brain atlas from Paxinos and Franklin was used as reference.
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Images were further processed with ImageJ Software 1.52k (National Institutes of Health, 
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Brussels, Belgium), followed by a transcardial perfusion with ice-cold PBS. Then, the brains 257 samples were surgically removed and the hemispheres were split. Both hemispheres were 258 snap frozen in liquid nitrogen and stored in separate tubes at −80°C. Next, to extract the sAβ 259 fraction, samples (100mg tissue/mL) were homogenized in a 0.2% diethylamine solution (DEA, 260 0.2% in 50mM NaCl), using a motor-driven tissue grinder for 30 s. Then, the samples were 261 centrifuged at 20 800 g for 90 min at 4°C to clarify the homogenate. The next step consisted 262 in collecting the supernatant and centrifuging it at 20 800 g for 20 min at 4°C. As the sAβ 263 fraction was restrained to the resulting supernatant, the latter was collected and immediately 264 neutralized by adding 1/10 volume 0.5 M Tris HCl (pH 6.8). The samples for ELISA were stored 265 at -80°C. Finally, sandwich ELISA (IBL International GMBH, 27729) was performed to 266 determine the levels of sAβ1-x, according to the manufacturer's guidelines. The ELISA signal 267 was quantified using a microplate reader (EnVision 2103 Multilabel Reader, PerkinElmer).
268
Statistical analyses. All statistical analyses were first performed including the three groups 269 (WT, tTA and TG). As no significant differences were found between the two control groups 270 (i.e. WT and tTA), these control genotypes were treated equally and the data from these two 271 groups was collapsed as one control group (Ctrl) [31] .
272
ROI-based analysis was assessed using a linear mixed model in JMP Pro 14.0, with Time,
273
Genotype, the interaction [Time*Genotype] as fixed effect and subject as random effect.
274
Tukey's HSD (honestly significant difference) test with p<0.05 was used as post hoc test. A 275 false discovery rate (FDR) correction (p<0.05) was applied to account for the multiple testing,
276
while performing multiple analyses in parallel. GraphPad Prism was used to make the graphs.
277
All results are shown as mean ± SEM (standard error of mean).
278
For ex vivo data, ELISA test was analysed in JMP Pro 14.0 using a non-parametric Wilcoxon 279 test to test for the main effect of genotype at 8w post DOX treatment. 
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RESULTS
281
290
The naming of each component was chosen based on the main anatomical brain regions 291 included in the component (Table 1) . The remaining components consisted of some duplicates 292 (one bilateral and two unilateral in the left and right primary somatosensory cortex), three were 293 localized in the cerebellum, one in the brainstem and two non-neuronal components in the 294 ventricles; these components were considered of no interest and were not further analysed. 
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The outcome of the statistical analyses is summarized in Table 2 . To further understand which 322 networks contributed to this pattern of connectivity, we then performed similar analysis 323 restricted within three networks (DMN, Sensory, and subcortical). 
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Interestingly, a significant hypersynchronisation was observed in the DMN of TG animals 328 (p=0.0114) relative to controls at 8w post-DOX treatment and FC was then decreased in a 329 similar way to the whole brain analysis leading to a significant hyposynchronisation relative to 330 controls at 28w post-DOX treatment (p=0.0008, Figure 2B ). On the contrary, no significant 331 differences were found within the sensory and subcortical networks at any time point ( Figure   332 2 C-D) indicating that the effect was more specific to the DMN.
333
TG mice showed altered FC within the DMN. As the biggest differences were found in the 334 DMN, we further investigated this network, in order to assess which regions were more 335 affected. Figure 3 illustrates the difference of the average FC (TG -Ctrl) of a specific region 336 within the DMN over time by spherical nodes localized in that brain region and scaled according 337 to the amplitude of the FC difference (see also Additional Figure 3 for time-courses and Table   338 3 for a summary of the statistical analysis). 
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At week 0 post DOX treatment, most of the regions showed small differences ( Figure 3A) . At 348 8w post DOX treatment, the FC differences were larger, reflecting an increased FC in the TG 349 animals for all regions ( Figure 3B ). More specifically, the TG mice showed a significant functionally connected to each other. Therefore, we looked at the difference in FC between 371 each pair of regions in the DMN, between the TG and controls (Figure 3; lines) . A summary of 372 the statistical analyses performed on the inter-regional FC is presented in Table 4 . 
373
375
Abbreviations: see Table 1 .
377
The inter-regional FC differences followed a similar time pattern as the average FC per region.
378
We observed an overall increased FC in the TG animals compared to the controls at 8w post 379 DOX treatment ( Figure 3B 
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In addition, two connections showed a trend, the posterior part of the cingulate-anterior part of 401 the retrosplenial cortex with the frontal cortex (p=0.0745) and the posterior part of the 402 retrosplenial cortex with the parietal association cortex (p=0.0514). On the other hand, at 28w 403 post DOX treatment, the TG mice showed lower inter-regional FC compared to the control 
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DISCUSSION
438
This study aimed to address the effects of sAβ on the neuronal networks in mature-439 onset amyloidosis TG mice. By inducing APP overexpression only once the main 440 developmental processes have occurred, we avoided the possible impact of protein 441 overexpression on the brain during postnatal development and its potential consequences later 442 on, once the brain is mature. We conjecture, that this model can thus provide valuable 
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Here, by controlling chimeric APP expression in the Tet-Off APP model, we could for 454 the first time demonstrate spatiotemporal dynamics of brain networks in mature-onset mice by 455 means of non-invasive and translational rsfMRI. Particularly, we could assess the impact of 456 increased sAβ levels on the brain networks from the initial stages up to abundant Aβ plaque 457 deposition, and correlate the neuronal network alterations to sAβ-induced synaptic toxicity.
458
Of note, at week 0 post DOX treatment, the TG mice did not show any significant 459 difference in FC compared to the controls. While the TG animals carry genetic mutations, those 460 manipulations had no detectable or apparent effect on the normal brain networks function 461 during the suppression phase of APP transgene expression. However, 8w later, the TG 462 animals showed a significant hypersynchronisation in the DMN, in which both intra-and 463 inter(sub)network FC were significantly higher compared to the controls (Figure 2B, 3B, 4 and 
464
Additional Figure 3 ). This hypersynchronisation of the neuronal networks in the TG mice coincided with a significant increase of total sAβ levels in absence of plaques ( Figure 5) , 466 suggesting a sAβ-induced toxicity affecting the brain networks and the communication 467 between them before plaque deposition. Moreover, this neuronal network 468 hypersynchronisation was not associated with any detectable inflammatory responses ( Figure   469 6), while neuroinflammation is an important feature of human AD pathology. Thus, our current 470 results showed an early hypersynchronisation of brain networks associated with sAβ increases 471 similarly to previously reported studies using developmental-onset mouse models [29] .
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Noteworthy, the brain networks affected were strongly model-dependent, making the 473 comparison between studies difficult. For instance, 3-month-old TG2576 mice showed early 474 hypersynchronisation in the hippocampus, followed by a hypersynchronisation in the DMN, the 475 thalamus, the cingulate and piriform cortices two months later. These alterations of brain 476 networks were demonstrated to be associated with an increased ratio of excitatory/inhibitory 
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On the contrary, an overexpression of APP could lead to an opposite effect, being toxic for the 488 neurons. Furthermore, the promotor used to construct the transgene may also have an impact, 489 inducing strong and persistent transgene expression not per se restricted to neurons, or to the 490 brain, with some active in utero. Some of these effects have been reported in the literature, 491 e.g. a persistent locomotor hyperactivity in adult mice [34] , an overall reduction in the number 492 of adult-generated hippocampal neurons [41] , cognitive deficits and pathological features unrelated to Aβ levels [42] or an abnormal electroencephalogram (EEG) activity [43] . However, 494 the early intra-and internetwork FC hypersynchronisation seems to be due to increased sAβ 495 levels rather than the effect of APP overexpression, as demonstrated in the knock-in APP NL-496 F/NL-F mouse model of amyloidosis expressing APP at physiological level, which exclude the 497 interference of APP artefacts [44] . Interestingly, a similar phenomenon was observed in 498 humans. Asymptomatic young adults with fAD showed greater activation in the right anterior 499 hippocampus compared to matched controls [45] . Cognitively-intact children at genetic risk for 500 fAD showed an early hypersynchronisation of the DMN, which coincided with significant higher 501 plasma levels of . Furthermore, healthy young adult APOE-ε4 carriers (known as 502 greatest genetic risk factor for sAD) displayed increased activation in the DMN [47, 48] and in 503 the hippocampus [49] . This hyperactivation seems to be persistent in the hippocampus of older 504 adult APOE-ε4 carriers [50] . Interestingly, at 16w post DOX treatment, the TG mice showed 505 similar FC values as compared to the controls. This decreased FC comparable to controls' FC 506 might be explained by the decreased of sAβ levels, as the Aβ plaques started to deposit around 507 this time point as confirmed by Thioflavin-S staining of brain slices (data not shown),
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suggesting that the plaques might be inert, protecting the brain from sAβ toxicity, as a dynamic 509 equilibrium might exist between toxic oligomers and inert plaques [51] .
510
Nevertheless, the continuous production and accumulation of sAβ revealed to 511 exacerbate its toxicity after the wide-spread deposition of amyloid plaques in cortical areas and 512 hippocampus. Indeed, at 28w post DOX treatment, an overall hyposynchronisation within and 513 between brain networks were observed in the TG mice, and more specifically in the DMN.
514
These findings are consistent with previously reported studies using developmental-onset 515 amyloidosis models in which significantly weaker intra-and internetwork FC was observed at 516 advanced stages of Aβ pathology [27, 29, 44] . In effect, 18-month-old APP/PS1 mice (plaques 517 deposition starting at 2m of age) showed weaker FC across the entire brain, as well as lower 518 interhemispheric FC in the somatosensory cortex and the hippocampus at advanced stages 519 of Aβ pathology [27] . In the knock-in APP NL-F/NL-F mice (plaques deposition starting at 6m 520 of age), a telencephalic hyposynchronized FC was found at 7m of age, as well as 521 hyposynchronized FC between hippocampus and prefrontal cortex, striatum and 522 hippocampus, and striatum and cingulate cortex [44] . However, the TG2576 and PDAPP mice 523 demonstrated hyposynchronisation of brain networks before Aβ plaque deposition, which 524 worsened with age [29] . These observations are in agreement with human data. Indeed, 525 patients with mild cognitive impairment and AD patients demonstrated to have a consistent 526 decreased FC in the DMN compared to healthy controls [17, 52, 53] . Interestingly, the regions 527 prone to sAβ-induced hypersynchronisation in absence of plaques tend to deteriorate into 528 subsequent hyposynchronisation after Aβ plaque burden. This decrease connectivity in the 529 neuronal networks seems to be caused by a progressive sAβ-induced synaptic damage.
530
Since sAβ is continuously produced and amyloid plaques might also serve as a 531 reservoir, the subsequent gradual and persistent synaptic loss reflected by first a 
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CONCLUSION
555
In the present study, our results indicate that abnormalities in neuronal network FC, 556 associated with sAβ synaptotoxicity, also occur when APP expression is induced once the 557 brain is mature. As the developmental influence of APP and/or sAβ has been avoided, this 558 precludes that these deleterious effects on the neuronal networks were caused during 559 postnatal brain development or a consequence of its high exposure during this critical period. 
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